Published 05 Mar.2020 09:24(KST)
[Asia Economy Reporter Park Jihwan] KemOn announced on the 5th that it has signed a research contract for toxicity testing using rodents for combination drugs worth 2.075 billion KRW.
This corresponds to 10.7% of recent sales revenue.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.